BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 20685398)

  • 21. In silico carborane docking to proteins and potential drug targets.
    Calvaresi M; Zerbetto F
    J Chem Inf Model; 2011 Aug; 51(8):1882-96. PubMed ID: 21774557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of biomolecular interactions with complex-binding small molecules.
    Cai Z; Greene MI; Berezov A
    Methods; 2008 Sep; 46(1):39-46. PubMed ID: 18571508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In search of negative allosteric modulators of biological targets.
    Groebe DR
    Drug Discov Today; 2009 Jan; 14(1-2):41-9. PubMed ID: 18973826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemical proteomics and discovery of drug targets].
    Yang HQ; Li XJ
    Yao Xue Xue Bao; 2011 Aug; 46(8):877-82. PubMed ID: 22007509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted scoring functions for virtual screening.
    Seifert MH
    Drug Discov Today; 2009 Jun; 14(11-12):562-9. PubMed ID: 19508918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a rule-based method for the assessment of protein druggability.
    Perola E; Herman L; Weiss J
    J Chem Inf Model; 2012 Apr; 52(4):1027-38. PubMed ID: 22448735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A chemogenomic approach to drug discovery: focus on cardiovascular diseases.
    Cases M; Mestres J
    Drug Discov Today; 2009 May; 14(9-10):479-85. PubMed ID: 19429507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physics-based methods for studying protein-ligand interactions.
    Huang N; Jacobson MP
    Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Druggability indices for protein targets derived from NMR-based screening data.
    Hajduk PJ; Huth JR; Fesik SW
    J Med Chem; 2005 Apr; 48(7):2518-25. PubMed ID: 15801841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PockDrug-Server: a new web server for predicting pocket druggability on holo and apo proteins.
    Hussein HA; Borrel A; Geneix C; Petitjean M; Regad L; Camproux AC
    Nucleic Acids Res; 2015 Jul; 43(W1):W436-42. PubMed ID: 25956651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alignment-free ultra-high-throughput comparison of druggable protein-ligand binding sites.
    Weill N; Rognan D
    J Chem Inf Model; 2010 Jan; 50(1):123-35. PubMed ID: 20058856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designing transient binding drugs: a new concept for drug discovery.
    Ohlson S
    Drug Discov Today; 2008 May; 13(9-10):433-9. PubMed ID: 18468561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding site druggability assessment in fragment-based drug design.
    Zhou Y; Huang N
    Methods Mol Biol; 2015; 1289():13-21. PubMed ID: 25709029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Docking and scoring in virtual screening for drug discovery: methods and applications.
    Kitchen DB; Decornez H; Furr JR; Bajorath J
    Nat Rev Drug Discov; 2004 Nov; 3(11):935-49. PubMed ID: 15520816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational chemistry approaches to drug discovery in signal transduction.
    Fischer PM
    Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding site detection and druggability index from first principles.
    Seco J; Luque FJ; Barril X
    J Med Chem; 2009 Apr; 52(8):2363-71. PubMed ID: 19296650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.